COLLEGIUM PHARMACEUTICAL, INC (COLL) insider trading

By person

16 insiders · 15 transactions

There is no salary here to measure against. COLLEGIUM PHARMACEUTICAL, INC's chief executive is paid a token, so dividing a holding by it says nothing.

Which is why this company is in neither direction of the chief executive filter on the transactions page. A stake that cannot be expressed as a multiple is not the same thing as a small one.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Scott Dreyer

EVP & Chief Commercial Officer

—

$2.87M (4) scheduled

−$2.87M

71,770

0.2205%

$2.44M

−32.2%

John A. Fallon

Director

—

$1.65M (1) scheduled

−$1.65M

64,634

0.1985%

$2.20M

+17.9%

Colleen Tupper

EVP & Chief Financial Officer

—

$1.22M (2) scheduled

−$1.22M

147,282

0.4524%

$5.01M

+12.6%

David Dieter

EVP & General Counsel

—

$716.21K (2) scheduled

−$716.21K

77,071

0.2367%

$2.62M

+733.7%

Garen G Bohlin

Director

—

$323.49K (1) scheduled

−$323.49K

71,000

0.2181%

$2.42M

+35.3%

Rita J. Balice-Gordon

Director

—

$171.67K (1)

−$171.67K

61,370

0.1885%

$2.09M

+32.0%

Nancy Lurker

Director

—

$161.86K (1)

−$161.86K

26,758

0.0822%

$911.11K

—

John Gordon Freund

Director

—

$143.23K (2) scheduled

−$143.23K

107,081

0.3289%

$3.65M

+22.7%

Rubric Capital Management LP entity

10% owner

—

3,132,743

9.62%

$106.67M

−0.8%

Vikram Karnani

President and CEO

—

197,864

0.6078%

$6.74M

+52,523%

Gino Santini

Director

—

112,483

0.3455%

$3.83M

+48.7%

Shirley R. Kuhlmann

EVP and General Counsel

—

108,137

0.3322%

$3.68M

−9.3%

Thomas B Smith

EVP and Chief Medical Officer

—

90,651

0.2784%

$3.09M

+63.8%

Michael Thomas Heffernan

Director

—

50,328

0.1546%

$1.71M

+10.6%

Carlos Paya V

Director

—

28,323

0.0870%

$964.40K

—

Donovan Michael Glancy

Director

—

17,482

0.0537%

$595.26K

—

COLLEGIUM PHARMACEUTICAL, INC

What the insiders did Mostly scheduled

By person